| Literature DB >> 21047800 |
Narendra Vaish1, Feng Chen, Shaguna Seth, Kathy Fosnaugh, Yan Liu, Roger Adami, Tod Brown, Yan Chen, Pierrot Harvie, Rachel Johns, Gregory Severson, Brian Granger, Patrick Charmley, Michael Houston, Michael V Templin, Barry Polisky.
Abstract
siRNAs confer sequence specific and robust silencing of mRNA. By virtue of these properties, siRNAs have become therapeutic candidates for disease intervention. However, their use as therapeutic agents can be hampered by unintended off-target effects by either or both strands of the siRNA duplex. We report here that unlocked nucleobase analogs (UNAs) confer desirable properties to siRNAs. Addition of a single UNA at the 5'-terminus of the passenger strand blocks participation of the passenger strand in RISC-mediated target down-regulation with a concomitant increase in guide strand activity. Placement of a UNA in the seed region of the guide strand prevents miRNA-like off-target silencing without compromising siRNA activity. Most significantly, combined substitution of UNA at the 3'-termini of both strands, the addition of a UNA at the 5'-terminus of the passenger strand, and a single UNA in the seed region of the guide strand, reduced the global off-target events by more than 10-fold compared to unmodified siRNA. The reduction in off-target events was specific to UNA placement in the siRNA, with no apparent new off-target events. Taken together, these results indicate that when strategically placed, UNA substitutions have important implications for the design of safe and effective siRNA-based therapeutics.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21047800 PMCID: PMC3061082 DOI: 10.1093/nar/gkq961
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.Effect of UNA position in the guide strand on siRNA activity. (a) Structures of UNA and RNA monomers. (b) ApoB specific siRNA sequences. (c) Position dependence of UNA on siRNA activity of ApoB knockdown in HepG2 cells. siRNA concentration at 5 nM.
Figure 2.UNA promotes strand specific activity. (a) UNA at the 5′-terminus of the passenger strand reduced its activity in a dual-luciferase assay. Black circles indicate UNA positions. Data represent an average of three replicates ±95% CI; IC50 determined on ApoB mRNA in HepG2 cells. (b) Blocking passenger strand activity increased guide strand activity. Activity of SOS1 siRNA on guide strand specific and passenger strand specific targets; data represent an average of three replicates ±95% CI.
Figure 3.UNA inhibits miRNA-like off-target silencing. (a) Rationale of reduced miRNA-like off-target silencing. Tm values were calculated at ‘The DINAMelt Server’ (http://www.bioinfo.rpi.edu/applications/hybrid/) using [Na+] = 1 M and strand concentration at 1 µM (25). Predicted Tm values for duplexes containing UNA were calculated by subtracting 7°C from the calculated Tm (2,4). (b) Effect of UNA position on reducing seed region-mediated off-targeting. Assay was carried out in HeLa cells using a siRNA sensor plasmid containing a full matched RISC target and a miRNA sensor plasmid containing four miRNA targets. miRNA target was designed to pair nts 1–8 of the siRNA guide strand (seed region) with one Watson–Crick and one Wobble base pair in the 3′-half of the siRNA. (c) siRNA (on-target) versus miRNA (off-target) analysis. Ratio was calculated by dividing normalized luciferase signals in siRNA sensor plasmid to normalize luciferase signals in miRNA sensor plasmid.
Figure 4.Specific placement of UNA in an siRNA significantly improves target specificity. siRNA was transfected in HepG2 cells. Off-target analysis was carried out on Affymetrix's Human Genome U133 Plus 2.0 GeneChip. (a) Sequences used for microarray analysis. (b) Intersample variability at >2-fold, P < 0.05, baseline average of all samples. Red indicates down-regulated mRNA expression and green indicates up-regulated mRNA expression from the baseline average. No siRNA indicates treatment with the delivery vehicle RNAiMAX alone. (c) Plots of log 2 change over baseline versus average intensity. Average of no siRNA treatments was used as the baseline. Unmodified siRNA treatment showed 389 genes that were changed >2-fold (P < 0.05) from the no siRNA control baseline. UNA-T siRNA treatment demonstrated 227 genes that were changed >2-fold (P < 0.05) from the no siRNA control. UNAP-1 siRNA treatment showed 215 genes changed >2-fold (P < 0.05). UNAP-1, UNAG7 siRNA treatment showed 35 genes changed >2-fold (P < 0.05). Blue diamonds represent ApoB gene. (d) Venn diagram showing the relationship between three siRNA and UsiRNA groups on genes with >2-fold change, P < 0.05. (e) Guide strand (GS) and passenger strand (PS) seed region analyses of the siRNA off-site target genes. Seed region complements (nts 2–7) of guide and passenger strands were used to search for complements in 3′UTRs of the 389 genes from the unmodified siRNA group using a custom Perl script. A maximum of eight seed region complements per 3′UTR were found for the guide strand and a maximum of five seed region complements per 3′UTR were found for the passenger strand.